IPEC: Risk Assessment Guide for Excipients now available
Recommendation

6/7 October 2026
The new version 1 of the "IPEC Risk Assessment Guide for Pharmaceutical Excipients - Risk Assessment for Excipient Manufacturers (Version 1, 2025)" has just been published on the website of the IPEC (International Pharmaceutical Excipients Council Europe (IPEC Europe)). This guide has been available to IPEC members in the members' area since May 2025 only and can now be accessed under "Resources" in the "Guidelines" section.
The table of contents of version 1 of the new guide published in 2025 includes the following chapters, with chapters 1, 2, and 4 containing further subchapters and subsections. This is an overview of the main chapters:
ACKNOWLEDGEMENTS
1 INTRODUCTION
2 PRINCIPLES OF RISK ASSESSMENT AND MANAGEMENT
3 RISK ASSESSMENT METHODS
4 RISK ASSESSMENT BY EXCIPIENT MANUFACTURER
5 REFERENCES
The full version 1 of the "IPEC Risk Assessment Guide for Pharmaceutical Excipients - Risk Assessment for Excipient Manufacturers (Version 1, 2025)" can be found on the IPEC website.
Related GMP News
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications
16.09.2026IPEC: Updated Qualification-Guide published
09.09.2026IPEC: New Stability Guide for Excipients Published
12.08.2026FDA Warning Letter for an Indian API Manufacturer
29.07.2026EPRS publishes a Briefing Paper on PFAS


